SEC Form D · filed January 16, 2020
Aligos Therapeutics, Inc
Location
South San Francisco, CA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (34)
Leonid Beigelman · South San Francisco, CAExec · DirectorLucinda A. Quan · South San Francisco, CAExecJulian P. Symons · South San Francisco, CAExecPeter A. Hirth · South San Francisco, CADirectorLawrence M. Blatt · South San Francisco, CAExec · DirectorJack A. Nielsen · South San Francisco, CADirectorCarole Neuchterlein · Ann Arbor, MIDirectorKathleen Glaub · REDWOOD CITY, CADirectorMichael Yi · Beltsville, MDDirectorTom Woiwode · South San Francisco, CADirectorJohn Fry · High Point, NCExecCaoimhghin O'Donnell · Luxembourg, LuxembourgExec · DirectorAlice H. Vilma · New York, NYDirectorCarla A. Harris · New York, NYExecDavid C. Schwab · Palo Alto, CAExecLawrence M. Blatt · South San Francisco, CAExec · DirectorBradley N. Rothman · New York, NYDirectorPeter Moldt · San Mateo, CADirectorSushmita Chanda · South San Francisco, CAExecBrian Dowd · South San Francisco, CAExecHernan Kazah · Montevideo, X3DirectorAndre Penha · Sao Paulo/SP, GuernseyDirectorTony Wood · Vancouver, British Columbia, CanadaExecWilliam Howald · Vancouver, British Columbia, CanadaExecAndrew Pollard · Vancouver, British Columbia, CanadaExec · DirectorJohn Seaberg · Vancouver, British Columbia, CanadaExec · DirectorCarole Neuchterlein · Ann Arbor, MIDirectorPeter Moldt · San Carlos, CADirectorSushmita Chanda · South San Francisco, CAExecKathleen Glaub · REDWOOD CITY, CADirectorBrian Dowd · South San Francisco, CAExecMichael Yi · San Diego, CADirectorTom Woiwode · South San Francisco, CADirectorJohn Fry · London, United KingdomExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗